About this trial
Patients are to be approached to attend clinic who have been identified as being implanted with either a Lima Corporate Delta Revision TT, Delta One TT or the Delta Multihole Systems hip systems between 2011 and 2015, a minimum of 10 years since hip surgery. They will be x-rayed (AP pelvis and a lateral view) and have a clinical review in clinic.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
All adult patients who had Lima Corporate modular titanium acetabular component implants implanted between 2011 and 2015.
Trial design
Cohort
Prospective
Treatments tested in this trial
x-ray
RadiationAP view of pelvis
Treatment groups
Trial outcomes
Primary outcomes
The survivourship of the modular acetabular hip system at 10 years post-op
This study will be the largest study to look at the survivorship of this acetabular system. Survivorship will be to the point of revision and clinical outcome survivorship is to the point of radiological loosening and PROMs data collection.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: